# Preterm Labor

Preterm labor requires separating contractions unlikely to lead to imminent birth from true cervical change, then using time-limited interventions to complete antenatal corticosteroids, provide neuroprotection, and arrange delivery at an appropriate neonatal center.

**Clinical question:** How should clinicians identify and manage patients with suspected spontaneous preterm labor while avoiding unnecessary intervention?

Updated: 2026-08-21T01:29:22.498833+00:00

## What matters in practice
- Preterm labor is diagnosed by regular contractions with cervical dilation or effacement change, or contractions with cervical dilation of at least 2 cm at presentation; fewer than 10% of clinically diagnosed patients deliver within 7 days. [17]
- Risk stratification—not contractions alone—should determine intervention; transvaginal cervical length and fetal fibronectin are used to assess likelihood of imminent spontaneous preterm birth. [18][19][20]
- Acute tocolysis is principally a short-term strategy to allow antenatal corticosteroid administration or maternal transfer; systematic-review evidence has not shown direct neonatal outcome improvement from tocolysis itself. [2][6]
- For anticipated extreme preterm birth, antenatal transfer to a tertiary center, antenatal corticosteroids, peripartum magnesium sulfate, and delayed cord clamping when appropriate are key perinatal measures. [2][4]

## Confirm labor before treating contractions

The immediate decision is whether symptoms indicate a meaningful likelihood of spontaneous preterm delivery.

Preterm birth is birth from 20 0/7 through 36 6/7 weeks. Preterm labor is generally defined by regular uterine contractions accompanied by cervical dilation or effacement change, or regular contractions with cervical dilation of at least 2 cm at initial assessment. [17]

Clinical diagnosis is imprecise: fewer than 10% of patients given a clinical diagnosis of preterm labor deliver within 7 days. This low short-term event rate supports avoiding reflexive treatment of contractions without cervical change and instead using a structured assessment of delivery risk and potential benefit of intervention. [17][18]

Do not conflate intact-membrane preterm labor with all preterm birth. Preterm prelabor rupture of membranes and maternal or fetal conditions requiring indicated preterm delivery have distinct management pathways. [17]
- Document gestational age, contraction pattern, cervical examination findings and change over time, membrane status, fetal status, and maternal conditions that may require delivery rather than pregnancy prolongation. [17]
- Use transvaginal cervical-length assessment and/or fetal fibronectin as adjuncts when their result will alter disposition or acute intervention; cervical length measured between 16 and 24 weeks is a reasonably accurate predictor of spontaneous preterm birth, and qualitative fetal fibronectin has traditionally been used to assess imminent delivery in threatened preterm labor. [19][20]

*Decision-relevant distinction between threatened and established preterm labor. [17][18]*

| Clinical state | Supporting finding | Management implication |
| --- | --- | --- |
| Threatened preterm labor | Regular contractions without documented cervical change; diagnostic uncertainty is common. [17][18] | Risk-stratify rather than automatically initiating acute preterm-birth interventions. [17][18] |
| Preterm labor | Regular contractions with cervical dilation or effacement change, or dilation of at least 2 cm at presentation. [17] | Assess gestational age, fetal and maternal status, and candidacy for time-sensitive interventions. [17][18] |
| Preterm birth pathway other than intact-membrane labor | Prelabor membrane rupture or maternal/fetal indication for delivery. [17] | Use the condition-specific management pathway; prolongation may be inappropriate when delivery is indicated. [17] |

## Use pregnancy prolongation only to achieve a defined perinatal objective

The value of acute treatment is usually measured in hours to days, not in long-term suppression of contractions.

When delivery appears likely and no maternal or fetal contraindication exists, acute care should focus on completing antenatal corticosteroid exposure, providing magnesium sulfate for fetal neuroprotection when applicable, and arranging in-utero transfer to a center equipped for the anticipated gestational age and neonatal needs. [2][4]

Tocolysis may be useful when short-term delay is safe and permits timely antenatal corticosteroids or maternal transfer. However, a systematic review found that tocolytics have not been shown to improve neonatal outcomes directly, even though they can delay delivery sufficiently for antenatal corticosteroids. [2][6]

Available trial evidence includes beta-adrenergic agonists, cyclooxygenase inhibitors, calcium-channel blockers, oxytocin-receptor antagonists, magnesium sulfate, and nitric-oxide donors. Reviews describe calcium-channel blockers such as nifedipine as having a comparatively favorable effectiveness and safety profile relative to some less effective or more harmful alternatives, but the supplied evidence does not support a U.S. dosing regimen, hierarchy, or contraindication list. [3][24]
- Set an explicit endpoint before initiating tocolysis: facilitate antenatal corticosteroids, complete transfer, or both. [2][3][6]
- Do not represent tocolysis as a treatment proven to improve neonatal outcomes independent of corticosteroid exposure or transfer. [6]
- Avoid using the available excerpts to infer drug doses, duration of maintenance treatment, or agent-specific contraindications; those details require verification in current local and professional-society guidance.

### Extreme preterm birth

For anticipated birth before 27 weeks, management should be coordinated with neonatal services and should prioritize antenatal transfer to a tertiary center. Recommended best-practice measures include antenatal corticosteroids, peripartum magnesium sulfate to reduce neurological injury, and delayed cord clamping when appropriate. [2][4]
- Cesarean delivery is indicated for maternal life-threatening risk or when neonatal resuscitation is planned and labor would be detrimental to outcome; it should not be treated as a routine intervention solely because gestation is extremely early. [2]
- Interpret intrapartum fetal heart-rate monitoring cautiously at extreme gestations: signal loss is common, autonomic immaturity alters expected patterns, and evidence for benefit of monitoring specifically at extreme prematurity is lacking. [2]

*Purpose-directed acute interventions in threatened or established preterm labor. [2][4][6]*

| Intervention | Primary clinical purpose | Evidence-based limitation |
| --- | --- | --- |
| Antenatal corticosteroids | Facilitate fetal lung maturation when preterm birth is anticipated. [2][8][9] | The supplied excerpts do not provide a gestational-age window, agent, or dosing regimen. |
| Short-term tocolysis | Gain time for corticosteroids or in-utero transfer when safe. [2][3][6] | No demonstrated direct improvement in neonatal outcomes from tocolytics in the cited systematic review. [6] |
| Peripartum magnesium sulfate | Reduce neurological injury in very or extremely preterm infants. [2][4] | The supplied excerpts do not provide a U.S. eligibility threshold or infusion protocol. |
| Antenatal transfer | Enable delivery where maternal-fetal and neonatal resources match anticipated needs. [2] | Transfer should occur before delivery when clinically feasible and safe. [2] |

## Use cervical assessment and fetal fibronectin to refine disposition

Testing is most useful when a low- or high-risk result changes admission, transfer, or treatment decisions.

Transvaginal cervical-length assessment between 16 and 24 weeks is a reasonably accurate predictor of spontaneous preterm birth. In symptomatic patients, cervical assessment can help distinguish patients with contractions from those with a cervical phenotype more consistent with evolving preterm labor. [19]

Qualitative fetal fibronectin testing has traditionally been used to identify patients with threatened preterm labor who may be at risk for imminent delivery. Its clinical role is risk stratification rather than replacement for cervical examination or assessment for membrane rupture, infection, abruption, or indicated delivery. [20][17]

The supplied sources do not provide validated cervical-length cutoffs, fetal-fibronectin test thresholds, or a testing algorithm. Avoid applying local thresholds as if they were established by the evidence excerpts reviewed here.
- Order a test only if its result will change the plan for observation, discharge, admission, transfer, corticosteroids, magnesium sulfate, or tocolysis. [18][19][20]
- A concerning test result does not supersede clinical reasons for delivery or contraindications to delaying birth. [17][2]

*Adjunctive tests for suspected preterm labor. [19][20]*

| Test | Best-supported role in supplied evidence | Important limitation |
| --- | --- | --- |
| Transvaginal cervical length | Predictor of spontaneous preterm birth when assessed between 16 and 24 weeks. [19] | No decision cutoff or symptomatic-patient algorithm is supplied. |
| Qualitative fetal fibronectin | Traditional test for detecting imminent delivery risk in threatened preterm labor. [20] | Should complement, not replace, clinical assessment. [17][20] |

## Avoid interventions unsupported by a realistic delivery risk

False-positive clinical diagnosis exposes patients to unnecessary treatment and transfer.

Because most patients diagnosed clinically with preterm labor will not deliver within 7 days, treatment based solely on contractions risks overtreatment. Reassess cervical change and use adjunctive risk stratification when appropriate before committing patients to interventions intended for imminent birth. [17][18]

The purpose of tocolysis is commonly misunderstood. It is not evidence-based as a stand-alone strategy to improve neonatal outcomes; its defensible role is a brief, goal-directed delay for corticosteroids or transfer when maternal and fetal conditions permit. [2][6]

Magnesium sulfate should not be described simply as another routine tocolytic in this setting. In contemporary extreme-preterm management, its cited role is peripartum fetal neuroprotection. [2][4]
- Do not delay delivery when maternal or fetal circumstances make continued pregnancy unsafe; the cited extreme-preterm guidance reserves cesarean delivery for maternal life-threatening risk or anticipated neonatal benefit when labor would be detrimental. [2]
- Do not assume fetal monitoring at extreme gestation has the same interpretability or proven benefit as at later gestations. [2]
- Do not extrapolate historical beta-agonist efficacy in delaying delivery by 24 to 48 hours into a conclusion of neonatal benefit. [11][6]

*Common framing errors and corrective actions. [2][6][17]*

| Framing error | Why it matters | Corrective action |
| --- | --- | --- |
| “Contractions equal preterm labor” | Most clinically diagnosed patients do not deliver within 7 days. [17] | Require cervical assessment and assess near-term delivery risk. [17][18] |
| “Tocolysis treats the neonatal risk” | Direct neonatal outcome benefit has not been demonstrated. [6] | Use a short-term, explicit objective: steroids or transfer. [2][6] |
| “Extreme prematurity requires automatic cesarean delivery” | Mode of delivery requires individualized maternal and neonatal assessment. [2] | Coordinate obstetric and neonatal planning before delivery whenever feasible. [2] |

## Common questions

### Should contractions without cervical change be treated as preterm labor?

Not automatically. Clinical diagnosis is imprecise, and fewer than 10% of patients diagnosed with preterm labor deliver within 7 days. Assess for cervical change and use cervical length and/or fetal fibronectin selectively when results will change management. [17][18][19][20]

### What is the main purpose of tocolysis?

Its supported role is short-term delay when safe to permit antenatal corticosteroids or maternal transfer. A systematic review found no demonstrated direct neonatal outcome benefit from tocolytics themselves. [2][6]

### When is maternal transfer particularly important?

When extreme preterm birth is anticipated, transfer before delivery to a tertiary center with appropriate neonatal capability is a recommended best-practice measure when feasible. [2]

### What is magnesium sulfate used for in extreme preterm birth?

Peripartum magnesium sulfate is used for fetal neuroprotection to reduce neurological injury in very or extremely preterm infants; the supplied sources do not provide a U.S. gestational-age criterion or dosing protocol. [2][4]

## References
1. BMJ Open is committed to open peer review. As ... — bmjopen.bmj.com — https://bmjopen.bmj.com/content/bmjopen/10/6/e036587.draft-revisions.pdf
2. Management and outcomes of extreme preterm birth | The BMJ — www.bmj.com — https://www.bmj.com/content/376/bmj-2021-055924
3. Supplemental material — gh.bmj.com — https://gh.bmj.com/content/bmjgh/8/12/e013109/DC2/embed/inline-supplementary-material-2.pdf
4. Perinatal management of extreme preterm birth before 27 ... — fn.bmj.com — https://fn.bmj.com/content/105/3/232
5. Study protocol for a randomised trial for atosiban versus placebo ... — bmjopen.bmj.com — https://bmjopen.bmj.com/content/bmjopen/9/11/e029101.full.pdf
6. Tocolytic therapy for preterm delivery: systematic review ... — www.bmj.com — https://www.bmj.com/content/345/bmj.e6226
7. Supplementary appendix — www.thelancet.com — https://www.thelancet.com/cms/10.1016/S0140-6736(23)00355-0/attachment/0b67a092-710b-4841-8e75-bdf46b2fceba/mmc1.pdf
8. Cost-effectiveness of antenatal corticosteroids and tocolytic ... — www.thelancet.com — https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00226-7/fulltext
9. Assessment of an intervention to optimise antenatal ... — bmjopen.bmj.com — https://bmjopen.bmj.com/content/bmjopen/11/9/e054711.full.pdf
10. Metronidazole to Prevent Preterm Delivery in Pregnant ... — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJM200002243420802
11. Treatment of Preterm Labor with the Beta-Adrenergic ... — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJM199207303270503
12. Prevention of Recurrent Preterm Delivery by 17 Alpha- ... — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMoa035140
13. Preterm Birth and 17OHP — Why the FDA Should Not ... — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMp2031727
14. The shifting landscape of the preterm brain: Neuron — www.cell.com — https://www.cell.com/neuron/abstract/S0896-6273(25)00224-7
15. ACOG Publications : Obstetrics & Gynecology — journals.lww.com — https://journals.lww.com/greenjournal/fulltext/2021/11000/acog_publications__november_2021.25.aspx
16. First and Second Stage Labor Management — journals.lww.com — https://journals.lww.com/greenjournal/fulltext/10.1097/aog.0000000000005447~first-and-second-stage-labor-management-acog-clinical
17. Practice Bulletin No. 171: Management of Preterm... : Obstetrics & Gynecology — journals.lww.com — https://journals.lww.com/greenjournal/fulltext/10.1097/aog.0000000000001711~practice-bulletin-no-171-management-of-preterm-labor
18. Practice Bulletin No. 171 Summary: Management of... : Obstetrics & Gynecology — journals.lww.com — https://journals.lww.com/greenjournal/fulltext/10.1097/aog.0000000000001702~practice-bulletin-no-171-summary-management-of-preterm-labor
19. Predicting preterm birth: Cervical length and fetal fibronectin — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0146000517300903
20. is the combination of fetal fibronectin and cervical length in ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0002937812022211
21. Preterm Birth Therapies to Target Inflammation - Pavlidis - 2022 — accp1.onlinelibrary.wiley.com — https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2107
22. Treatment of spontaneous preterm labour with retosiban: a phase II ... — bpspubs.onlinelibrary.wiley.com — https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.13336
23. FIGO good practice recommendations on preconception care ... — obgyn.onlinelibrary.wiley.com — https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.70495
24. Therapeutic role of nifedipine in threatened preterm labor ... — obgyn.onlinelibrary.wiley.com — https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.70816

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.